Filing Details

Accession Number:
0001638599-19-000654
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-15 17:46:39
Reporting Period:
2019-07-11
Accepted Time:
2019-07-15 17:46:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682639 Eyenovia Inc. EYEN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1396235 H Curt Labelle C/O Eyenovia, Inc.
295 Madison Avenue, Suite 2400
New York NY 10017
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Acquisiton 2019-07-11 17,985 $2.78 27,985 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $.0001 606,667 Indirect By Private Medical Equity, Inc.
Common Stock, Par Value $.0001 453,333 Indirect By PME Investor Services Eyenovia, LLC
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $1.24 2015-03-02 2025-03-02 40,000 40,000 Direct
Common Stock Stock Option (right to buy) $1.95 2027-07-07 133,334 133,334 Direct
Common Stock Stock Option (right to buy) $1.24 2015-03-23 2025-03-23 140,000 140,000 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-03-02 40,000 40,000 Direct
2027-07-07 133,334 133,334 Direct
2025-03-23 140,000 140,000 Indirect
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  2. The option became exercisable as to 3,704 shares on August 7, 2017, and becomes exercisable in equal 3,704 share amounts on each of the 35 one-month anniversaries thereafter.